Since knockdown of p100 resulted in deficiency of both p100 and p52, our subsequent experiment focused on the identifying which of p100 or p52, was responsible for above inhibition of human bladder cancer cell growth. The gene discussed is NFKB2; the disease is urinary bladder cancer.